Transcatheter Device Closure of Atrial Septal Defects A Safety Review

被引：154

作者：

Moore, John ^{[1
]}

Hegde, Sanjeet ^{[1
]}

El-Said, Howaida ^{[1
]}

Beekman, Robert, III ^{[2
]}

Benson, Lee ^{[3
]}

Bergersen, Lisa ^{[4
]}

Holzer, Ralf ^{[5
]}

Jenkins, Kathy ^{[4
]}

Ringel, Richard ^{[6
]}

Rome, Jonathan ^{[7
]}

Vincent, Robert ^{[8
]}

Martin, Gerard ^{[9
]}

机构：

[1] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp, Div Cardiol, San Diego, CA 92103 USA

[2] Cincinnati Childrens Hosp, Dept Pediat, Div Cardiol, Cincinnati, OH USA

[3] Hosp Sick Children, Dept Pediat, Div Cardiol, Toronto, ON M5G 1X8, Canada

[4] Harvard Univ, Sch Med, Dept Pediat, Div Cardiol,Childrens Hosp Boston, Boston, MA 02115 USA

[5] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Div Cardiol, Columbus, OH 43210 USA

[6] Johns Hopkins Childrens Ctr, Dept Pediat, Div Cardiol, Baltimore, MD USA

[7] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat,Div Cardiol, Philadelphia, PA 19104 USA

[8] Emory Univ, Sch Med, Dept Pediat, Div Cardiol,Childrens Healthcare Atlanta, Atlanta, GA USA

[9] George Washington Univ, Sch Med, Dept Pediat, Div Cardiol,Childrens Natl Med Ctr, Washington, DC 20052 USA

来源：

JACC-CARDIOVASCULAR INTERVENTIONS | 2013年 / 6卷 / 05期

关键词：

atrial septal defect; devices; erosions; PERCUTANEOUS CLOSURE; NATURAL-HISTORY; LONG-TERM; FOLLOW-UP; OCCLUDER; MANUFACTURER; ARRHYTHMIAS; SURGERY; EROSION;

D O I：

10.1016/j.jcin.2013.02.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review discusses the current safety issues related to U.S. Food and Drug Administration approved atrial septal defect devices and proposes a potential avenue to gather additional safety data including factors, which may be involved in device erosion. © 2013 American College of Cardiology Foundation.

引用

页码：433 / 442

页数：10

共 29 条

[1]

AGA Medical, 2001, AM SEP OCCL DEL SYST

[2] Surgery for atrial septal defect: From the first experiments to clinical practice [J].

Alexi-Meskishvili, VV ;

Konstantinov, IE .

ANNALS OF THORACIC SURGERY, 2003, 76 (01) :322-327

[3] Erosion of amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk [J].

Amin, Z ;

Hijazi, ZM ;

Bass, JL ;

Cheatham, JP ;

Hellenbrand, WE ;

Kleinman, CS .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 63 (04) :496-502

[4]

[Anonymous], BIRTH DEFECTS

[5]

[Anonymous], FDA EX SUMM MEM MAY

[6]

CAMPBELL M, 1970, BRIT HEART J, V32, P820

[7] NATURAL HISTORY AND PROGNOSIS OF ATRIAL SEPTAL DEFECT [J].

CRAIG, RJ ;

SELZER, A .

CIRCULATION, 1968, 37 (05) :805-&

[8] Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database [J].

DiBardino, Daniel J. ;

McElhinney, Doff B. ;

Kaza, Aditya K. ;

Mayer, John E., Jr. .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (06) :1334-1341

[9] Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder [J].

Divekar, A ;

Gaamangwe, T ;

Shaikh, N ;

Raabe, M ;

Ducas, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1213-1218

[10] Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults - Results of a multicenter nonrandomized trial [J].

Du, ZD ;

Hijazi, ZM ;

Kleinman, CS ;

Silverman, NH ;

Larnitz, K .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1836-1844

← 1 2 3 →